CA2529300C - Devices and methods relating to electrochemical biosensors - Google Patents

Devices and methods relating to electrochemical biosensors Download PDF

Info

Publication number
CA2529300C
CA2529300C CA2529300A CA2529300A CA2529300C CA 2529300 C CA2529300 C CA 2529300C CA 2529300 A CA2529300 A CA 2529300A CA 2529300 A CA2529300 A CA 2529300A CA 2529300 C CA2529300 C CA 2529300C
Authority
CA
Canada
Prior art keywords
electrodes
electrode
sample
test strip
pair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2529300A
Other languages
French (fr)
Other versions
CA2529300A1 (en
Inventor
Nigel Anthony Surridge
Paul Douglas Walling
Vladimir Svetnik
Melani Sullivan
Brian S. Hill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CA2529300A1 publication Critical patent/CA2529300A1/en
Application granted granted Critical
Publication of CA2529300C publication Critical patent/CA2529300C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3272Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material

Abstract

A system for testing for analytes in a sample of biological fluid includes a test strip that defines a cavity for receiving the sample. At least two sets of electrodes are adjacent the sample cavity, including one for measuring one property of the sample, and another for measuring one or more other properties of the sample, such as temperature and/or the presence or magnitude of confounding variables. The measurements are combined to yield the desired result. At least one set of working and counter electrodes each have a plurality of elongated "fingers" interdigitated with those of the other electrode in the set. The gaps between fingers can be quite small, so that the two electrode sets together can operate in a small measurement volume of sample. Additional electrodes can be included that measure the presence or sufficiency of the sample, and additional traces on the strip can act as configuration identifiers.

Description

DEVICES AND METHODS RELATING TO
ELECTROCHEMICAL BIOSENSORS

Background The present invention relates to devices, systems, and methods for measuring analytes from biological samples, such as from a sample of bodily fluid. More specifically, the present invention relates to biosensors and methods for testing an analyte using certain electrical response characteristics.
Measuring the concentration of substances, particularly in the presence of other, confounding substances ("interferents"), is important in many fields, and especially in medical diagnosis and disease management. For example, the measurement of glucose in bodily fluids, such as blood, is crucial to the effective treatment of diabetes.
Multiple methods are known for measuring the concentration of analytes such as glucose in a blood sample. Such methods typically fall into one of two categories: optical methods and electrochemical methods. Optical methods generally involve absorbance, reflectance or laser spectroscopy to observe the spectrum shift in the fluid caused by the concentration of the analytes, typically in conjunction with a reagent that produces a known color when combined with the analyte. Electrochemical methods generally rely upon the correlation between a charge-transfer or charge-movement property of the blood sample (e.g., current, interfacial potential, impedance, conductance, and the like) and the concentration of the analyte, typically in conjunction with a reagent that produces or modifies charge-carriers when combined with the analyte. See, for example, U.S. Patent Nos. 4,919,770 to Preidel, et al., and 6,054,039 to Shieh.

An important limitation of electrochemical methods of measuring the concentration of a chemical in blood is the effect of confounding variables on the impedance of a blood sample. For example, the geometry of the blood sample must correspond closely to that upon which the impedance-to-concentration mapping function is based.
The geometry of the blood sample is typically controlled by a sample-receiving portion of the testing apparatus. In the case of blood glucose meters, for example, the blood sample is typically placed onto a disposable test strip that plugs into the meter. The test strip may have a sample chamber to define the geometry of the sample. Alternatively, the effects of sample geometry may be limited by assuring an effectively infinite sample size. For example, the electrodes used for measuring the analyte may be spaced closely enough so that a drop of blood on the test strip extends substantially beyond the electrodes in all directions. Regardless of the strategy used to control sample geometry, typically one or more dose sufficiency electrodes are used to assure that there is a sufficient amount of sample to assure an accurate test result.
Other examples of limitations to the accuracy of blood glucose measurements include variations in blood chemistry (other than the analyte of interest being measured). For example, variations in hematocrit (concentration of red blood cells) or in the concentration of other chemicals, constituents or formed elements in the blood, may affect the measurement.
Variation in the temperature of blood samples is yet another example of a confounding variable in measuring blood chemistry.
Thus, a system and method are needed that accurately measure blood glucose, even in the presence of confounding variables, including variations in temperature, hematocrit, and the concentrations of other chemicals in the blood. A system and method are likewise needed that accurately measure an analyte in a fluid. It is an object of the present invention to provide such a system and method.
Many approaches have been employed to attenuate or mitigate the influence of one or more sources of interference, or to otherwise compensate for or correct a measured value. Often multiple design solutions are employed to adequately compensate for the sensitivities associated with the chosen measurement method.
Well known design solutions involve perm-selective and/or size-selective membranes, filters or coatings. Such design solutions suffer from incremental costs of goods, additive manufacturing process steps further exacerbating manufacturing cost, complexity, and speed of manufacture.
Systems (disposable test strips and instruments) employing these methods take the general approach of overcoming the problem within the scope of the test strip design.
Another general approach involves the use of sophisticated excitation and signal processing methods coupled with co-optimized algorithms.
Simpler, less complex, test strip architectures and manufacturing processes may be realized; however, instrumentation costs, memory and processor requirements, associated complex coding, and calibrated manufacturing techniques are required. Systems employing this technique take the general approach of overcoming the problem within the scope of the instrumentation.
A more recent approach involves neither the strip nor instrumentation, per se, but rather exploits the measurement methodology. An example of this is the use of a coulometric method to attenuate the influence of hematocrit and temperature.
It is also well known to those skilled in the art that all of the above approaches are further supported by the initial design of reagent systems. In the detection of glucose, for example, this may involve the use of selective redox mediators and enzymes to overcome the detrimental influence of redox-active species or the presence of other sugars.
It is an object of the invention to provide a simpler, less costly method for attenuating the influence of interferents, in a manner that does not suffer the demerits associated with the general approaches currently in wide use.
Summary of the Invention In accordance with one aspect of the invention, there is provided in a test strip that defines a capillary passageway, the passageway being dimensioned so as to induce movement of a sample of bodily fluid by capillary action along a predetermined path through the passageway, the improvement comprising: a first set of electrodes in electrical communication with the passageway for obtaining a first measurement correlated with the concentration of an analyte in the sample;
and a second set of electrodes in electrical communication with the passageway for obtaining a second measurement correlated with a property of the sample which affects the first measurement; one of the set of electrodes comprising a pair of electrodes with substantially parallel, interdigitated fingers, each electrode having at least two fingers, and each of the fingers being a first distance less than about 50 gm from the nearest other finger in the one set of electrodes, and the other set of electrodes comprising a pair of macro electrodes having one finger each spaced apart a second distance at least 50 gm.
In accordance with another aspect of the invention, there is provided a method of measuring the concentration of an analyte in a sample of bodily fluid, comprising: providing a test strip of the invention; obtaining a first response to an application of a first electrical signal to the first set of electrodes;
obtaining a second response to an application of a second electrical signal to the second set of electrodes; and using the first response and the second response to derive a measurement of the concentration of the analyte in the sample.

Two Pairs Generally.
In one' aspect, the present invention involves the provision of two pairs of electrodes, which allow for the use of two measurements to correct or 5 compensate the analyte measurement for interferents. In one embodiment for example, a pair of electrodes defines a first measurement zone, while a second pair defines a second measurement zone. The pairs are roughly coplanar, and within a pair of electrodes each has a length substantially parallel to the length of the other. At least one of the electrodes in the first pair of electrodes comprises at least two elongated, rectangular conductive elements, which are interdigitated with the conductive element(s) of the other electrode in the pair.
Each element for an electrode is conductively connected to the same contact for electrical communication with a driver and/or meter. The sample establishes electrical contact with both pairs after dosing.
Several variations of the foregoing are contemplated. For example, in one approach a reagent or a plurality of reagents can be selectively deployed onto at least one of the at least two pairs of electrodes residing in a sample chamber. Both pairs are coated with a first reagent. Optionally, one of the two pairs is coated with a first reagent, and the second pair is coated with the same reagent but lacking either enzyme or mediator. Alternatively, one of the two pairs is coated with a first reagent and the other pair is coated with a second reagent. In another embodiment, one of at least two pairs is coated with a reagent and the other pair lacks a reagent coating, with the downstream pair preferably having the reagent coating. In a variation of this embodiment, the other of the pairs is covered with a coating that is perm-selective, size-selective, or otherwise affects the electrode response in the presence of one or more analytes and/or interferents.
In further aspects, dose detection and dose sufficiency electrodes are included. For example, a third electrode system may be included that is located further from the edge than the first two electrode pairs, i.e. is downstream of the entering sample fluid, and is operable to detect when there is sufficient sample fluid to conduct an accurate test. This third electrode system may comprise a single electrode element or a plurality of elements. In single-element embodiments, the element functions in combination with one or more of the other electrodes to test for sample sufficiency. Alternatively, the dose sufficiency electrode system may comprise a pair of electrode elements that cooperate with one another to evidence sample sufficiency. A
comparable electrode system may similarly be employed to detect when a sample fluid has been applied to the biosensor.
Brief Description of the Drawings FIG. 1 is a perspective view of a testing strip according to one embodiment of the present invention.

FIG. 2 is an exploded view of selected layers of the test strip of FIG. 1.
FIG. 3 is a cutaway plan view of the electrode portion of the strip of FIG. 1.

FIGS. 4-15 are exploded views of alternative test strips according to the present invention.
Description For the purpose of promoting an understanding of the principles of the present invention, reference will now be made to the embodiments illustrated in the drawings and specific language will be used to describe the same. It will, nevertheless, be understood that no limitation of the scope of the invention is thereby intended; any alterations and further modifications of the described or illustrated embodiments, and any further applications of the principles of the invention as illustrated therein are contemplated as would normally occur to one skilled in the art to which the invention relates.

Introduction Generally, the test strips of the present invention provide for testing of an analyte in a bodily or other fluid using multiple electrode arrays that perform different functions or have different response functions with the sample. One particular embodiment involves the combination of macro-electrodes and micro-electrodes that operate in respective pairs, but contribute information for a final determination of the analyte concentration, such as by having the information obtained from one electrode pair being used to compensate or correct the results obtained from the other electrode pair, or by combining the responses of the electrode pairs in a predetermined fashion.
These electrode arrays may also be combined in a wide variety of other ways to accomplish multiple related functions, including analyze concentration, detection of hematocrit, determination of correction factors, as well as sample sufficiency and dose detection, all on a single strip and in an extremely small space. Alternatively, by using multiple arrays with different sensitivities to interferents, one may exploit the two measurements to provide a more accurate result, as would normally occur to one skilled in the art.
In various embodiments, different electrochemical excitation techniques (for example, DC, AC phase, AC amplitude, or combined DC/AC) are applied to these different electrode arrays to achieve the desired goals.
Examples of such techniques are well known in the art, and are further exemplified in the AC Excitation application, which was incorporated above by reference.
Another exemplary technique compensates for variation of diffusion coefficients of the electrochemically active species being tested. Faradaic current in soluble reagents at an electrode surface occurs due to the physical diffusion of these species and the value of the diffusion coefficient influences the measured response. Commercial systems are often calibrated and built such that the nominal sensor response (faradaic current) to a given amount of glucose is repeatable if the diffusion coefficients remain fixed.
Unfortunately both the temperature and hematocrit (HCT) of each individual sample alter the effective diffusion coefficient of the electroactive species being measured.
If these factors are not considered, the glucose measurement can be in error for any temperature or hematocrit value differing from those used in the calibration of the system.
In this exemplary technique, the system determines the faradaic response of an electrochemical sensor due to an analyte of interest, and provides an estimate of the actual, effective diffusion coefficient of the species undergoing the redox reaction at the electrode surface. In particular, the system compensates for diffusion coefficient variation by using two electrode systems (preferably of different types) exposed to the same reagent-sample mixture. Soluble, electroactive species, such as the redox mediators commonly employed in glucose biosensors, diffuse to a planar, macro-electrode yielding a current response to a potential step according to the Cottrell equation (1).

ip = nFAPC FDt so that (1a) lim i = 0 (lb) r -,t(-) P

where n is the number of electrons involved in the electron transfer, F is the Faraday constant (96,485.3 C/equivalent), Ap is the area of the macro-electrodes in contact with the solution, C is the concentration of the analyte in the sample, D is the effective diffusion coefficient of the species, and ip is the current response at the macro-electrode.
It will similarly be understood by those of skill in the art that the 5 response of these same species to the same potential step at a micro-electrode would yield a current response characterized by equation (2).

is = nFA,C FD + jOtZFACD so that (2a) ro hm i = nFAsCD (2b) t- t(oo) s r a where AS is the area of the micro-electrode, v is an electrode shape-dependent 10 accessibility factor and is is the current response at the micro-electrode at the micro-electrode. In equations (lb) and (2b), t(oo) means a time sufficiently long that the condition of "semi-infinite" or "steady-state" diffusion, respectively, can be established at the electrodes in question.
One embodiment would apply the same potential between (a) the planar, macro electrode and a counter/reference electrode, and between (b) the micro electrode(s) and counter/reference electrode. The time-dependent current response would then be measured at several time-points following potential application at both macro and microelectrodes. An analysis of ip = f would produce slopep, as in equation (3), while the same analysis of is = f ~tt j would yield an intercepts as shown in equation (4).

slopep = nFApC D (3) intercepts = nFACD S (4) ra Given that in this invention both ip and is are derived from the same reaction and sample, it is possible to calculate an apparent diffusion coefficient for the electrochemically reacting species in the device, independent of the concentration of the species according to equation (5), where the areas of the two electrode types, A, and AP, as well as the radius of the micro-electrode(s), r0, are known. For example, a spherical microelectrode yields:

intercept, _ AS TrD (5) slopep r.AP

Once D is estimated, it can be applied in a number of different ways to provide a correction for the measured concentration, C, of the electrochemical species.
Some embodiments simply use the estimated value of D in equation (3) to calculate C. Such a determination of C is less subject to uncompensated variation in D as is common in amperometric sensors whose current response is largely described by equation (1). It is also noteworthy that the correction is independent of the cause of variation in D (e.g., temperature, hematocrit, viscosity change, etc.)-the correction is provided by the different functional dependence of the two electrode pairs on the chemical properties of the sample.
In each of the strips illustrated herein, an electrode array is used to measure an analyte, such as glucose, in a sample. When the sample reaches the array, it combines with reagent that is placed adjacent to the array to provide certain properties of electrical impedance in the presence of a certain electrical signal, as is understood in the art, which impedance is used as a first datum. Another array, either upstream or downstream from the first array, but preferably not covered by a reagent, is used to provide another electrical stimulus to the sample, and the electrical response at the array is used as a second datum affected in a known way by an interferent, such as hematocrit temperature, or the like. This two data are combined to yield a corrected analyte concentration value. The two arrays can be used at the same time to analyze a single sample in a common volume of very small dimensions.
General Information System The present invention relates to a system that is useful for assessing an analyte in a sample fluid. The system includes devices and methods for evaluating the sample fluid for the target analyte. The evaluation may range from detecting the presence of the analyte to determining the concentration of the analyte. The analyte and the sample fluid may be any for which the test system is appropriate. For purposes of explanation only, a preferred embodiment is described in which the analyte is glucose and the sample fluid is blood or interstitial fluid. However, the present invention clearly is not so limited in scope.
Sensor One component of the system is an electrochemical sensor including a sample-receiving chamber for the sample fluid, and a reagent for producing an electrochemical signal in the presence of the test analyte. The sensor preferably comprises a disposable test strip, particularly one having a laminar construction providing an edge opening to a sample-receiving chamber. The reagent is disposed within the sample-receiving chamber in position to provide the electrochemical signal to a working electrode also positioned within the chamber. In appropriate circumstances, such as for glucose detection, the reagent may contain an enzyme and optionally a mediator.
Meter The sensor is used in combination with a meter for determination of the presence and/or concentration of the analyte in the sample fluid. The meter conventionally includes a connection with the electrodes of the sensor and circuitry to evaluate the electrochemical signal corresponding to the concentration of the analyte. The meter may also include means for determining that the sample fluid has been received by the sensor, and that the amount of sample fluid is sufficient for testing. The meter typically will store and display the results of the analysis, or may alternatively provide the data to a separate device.
Analyte - Characteristic The system can provide either a qualitative or quantitative indication for the analyte. In one embodiment, the system indicates simply the presence of the analyte in the sample fluid. The system may also provide a reading of the quantity or concentration of the analyte in the sample fluid. In a preferred embodiment, it is a feature of the present invention that a highly accurate and precise reading of the analyte concentration is obtained.
Anal3te - Type The system is useful for the determination of a wide variety of analytes. The test strip, for example, is readily adapted for use with any suitable chemistry that can be used to assess the presence of the analyte.
Most preferably, the system is configured and used for the testing of an analyte in a biological fluid. Such analytes may include, for example, glucose, lactate, urate, ketones, etc. Commensurate modifications to the system will be apparent to those skilled in the art. For purposes of explanation, and in a particularly preferred embodiment, the system is described with respect to the detection of glucose in a biological fluid.
Interferents Test methodologies may be variously affected by the presence of interferents in the sample fluid. For example, the testing for glucose in a blood sample may be impacted by such factors as bilirubin, hematocrit, uric acid, ascorbate, acetaminophen, galactose, maltose, and lipids. The present system is adaptable to minimize or eliminate the adverse effects of interferents that may also be present in the sample fluid. These effects may be addressed by appropriate selection of test materials and parameters, such as by the selection of chemistries that are known to be impacted less, or not at all, by possible interferents. They may also be addressed by selection of two or more reagents that have differential sensitivities to the interferent, but substantially the same sensitivity to the analyte of interest. As is known in the art, other steps may also be taken to deal with possible interferent effects, such as the use of coatings or films that prevent the interferent from entering the test zone.
In addition, modifications to the electrode configurations or interrogation methods can be used to minimize the effect of interferents.
Fluid Type The system is useful with a wide variety of sample fluids, and is preferably used for the detection of analytes in a biological fluid. In this context, the term "biological fluid" includes any body fluid in which the analyte can be measured, for example, interstitial fluid, dermal fluid, sweat, tears, urine, amniotic fluid, spinal fluid and blood. The term "blood" in the context of the invention includes whole blood and its cell-free components, namely plasma and serum. In addition, the system is useful in connection with reference fluids that are used in conventional fashion to verify the integrity of the system for testing.
In a preferred embodiment, the system is employed for the testing of glucose. The sample fluid in this instance may specifically include, for example, fresh capillary blood obtained from the finger tip or approved alternate sites (e.g., forearm, palm, upper arm, calf and thigh), fresh venous blood, and control solutions supplied with or for the system.
The fluid may be acquired and delivered to the test strip in any fashion.
For example, a blood sample may be obtained in conventional fashion by incising the skin, such as with a lancet, and then contacting the test strip with fluid that appears at the skin surface. It is an aspect of the present invention that the test strip is useful with very small fluid samples. It is therefore a desirable feature of the invention that only a slight incising of the skin is necessary to produce the volume of fluid required for the test, and the pain and other concerns with such method can be minimized or eliminated.

Electrodes Electrode Type The invention relates to an"electrochemical sensor", which is a device configured to detect the presence and/or measure the concentration of an analyte 5 by way of electrochemical oxidation and reduction reactions within the sensor, and/or development of movement of charged layers within the solution. These reactions are transduced to an electrical signal that can be correlated to an amount or concentration of the analyte. The test strip therefore includes an electrode system comprising at least a working electrode and a counter electrode within the 10 sample receiving chamber. The sample receiving chamber is configured such that sample fluid entering the chamber is placed in electrolytic contact with both the working electrode and the counter electrode. This allows electrical current to flow between the electrodes to effect the electrooxidation or electroreduction of the analyte or its products.
i5 In the context of the present invention, a "working electrode" is an electrode at which analyte or product is electrooxidized or electroreduced with or without the agency of a redox mediator. The term "counter electrode" refers herein to an electrode that is paired with the working electrode and through which passes an electrochemical current equal in magnitude and opposite in sign to the current passed through the working electrode. The term "counter electrode" is meant to include counter electrodes that also function as reference electrodes (i.e., a counter/reference or auxiliary electrode).
Electrode Material The working and counter electrodes, and the remaining portions of the electrode system, may be formed from a variety of materials, as known in the art.
The electrodes should have a relatively low electrical resistance and should be electrochemically inert over the operating range of the test strip. Suitable conductors for the working electrode include gold, palladium, platinum, carbon, titanium, ruthenium dioxide, iridium, and indium tin oxide, as well as others, such as the conductors disclosed in US 2005/0023152. The counter electrode may be made of the same or different materials. In a preferred embodiment, both of the electrodes are gold electrodes.
Electrode Application The electrode systems utilized by the present invention may be applied to the base substrate in any fashion that yields electrodes of adequate conductivity and integrity. Exemplary processes are well known in the art, and include, for example, sputtering, printing, etc. In a preferred embodiment, the electrodes and other conductive components are provided by coating a base substrate and then removing selected portions of the coating to yield the components. A preferred removal method is laser ablation, and more preferably broad-field laser ablation, as disclosed in the "Method of Making a Biosensor" application, and further relevant discussion is found in US 2002/0192115 (entitled "Biosensors with Laser Ablation Electrodes with a Continuous Coverlay Channel") and US 6,662,439 (entitled "Laser Defined Features for Patterned Laminates and Electrode").
Various other methods of fabrication and application are well known in the art for providing the electrical components, and particularly the electrode systems, described herein.
Reagent Composition The test strip includes a chemical reagent within the sample receiving chamber for reacting with the test analyte to produce the electrochemical signal that represents the presence of the analyte in the sample fluid. The test chemistry is selected in respect to the analyte to be assessed. As is well known in the art, there are numerous chemistries available for use with each of various analytes, including but not limited to the preferred chemistry described in US

titled "Reagent Stripe for Test Strip". The selection of an appropriate chemistry is therefore well within the skill in the art, and further description herein is not required in order to enable one to make and use the present invention.

For purposes herein, however, a preferred embodiment is described in which the analyte is glucose, although it is to be understood that the scope of the invention, and of the claims, is not so limited, unless specifically indicated. In the case of glucose, the active components of the test chemistry will typically include an enzyme for glucose and a redox mediator. The enzyme oxidizes glucose in the sample, and the mediator in turn reacts with the reduced enzyme. The mediator thereafter shuttles the redox equivalent of analyte product to the electrode surface by diffusion. There the mediator is oxidized quantitatively at a defined anodic potential and the resulting current is related to the apparent glucose concentration.
There are a number of reagent systems suitable for the detection of glucose, and examples of these are contained in US 2005/0023152, US 2004/0157339, US
2004/0194302, US 2005/0016844, U. S. Patent Nos. 5,385,846, 5,997,817, and 7,276,146.
The glucose chemistry utilizes the redox mediator to mediate a current between the working electrode and the glucose analyte, which otherwise is not well suited for direct electrochemical reaction on an electrode. The mediator functions as an electron transfer agent that shuttles electrons between the analyte and the electrode. A great number of redox species are known and can be used as the redox mediator. In general, the preferred redox mediators are rapidly reducible and oxidizable molecules. Examples include ferricyanide, nitrosoaniline and derivatives thereof, and ferrocene and its derivatives.
Measurement Scheme In one aspect of the present invention, a first pair of electrodes provides a first measurement that is combined with a second measurement obtained with a second pair of electrodes. As previously described, a conventional test strip employs at least two pairs of electrodes (each, e.g., a working electrode and a counter electrode) to determine the analyte concentration based upon the reaction of the analyte with a reagent located on or adjacent one of the electrode pairs. A basic measurement of the analyte concentration is thereby obtained. However, it is often desirable to correct or compensate that measurement for other factors, such as hematocrit, temperature, the presence of other species in the sample fluid, and the like.
In one embodiment of the present invention, there is provided a biosensor and method which employs two pairs of electrodes, one to make the basic measurement of the analyte and the other to provide such correction or compensation for the basic measurement, in some instances to yield a final measurement figure.
The use of two pairs of electrodes may involve the use of disparate electrode sets, in which one pair comprises macro-electrodes and the other pair comprises micro-electrodes. As used herein, the term macro-electrode refers to an electrode whose primary effective diffusion characteristic is perpendicular to the surface of the electrode. Macro-electrodes are dimensioned and arranged so that the primary diffusion characteristics are linear diffusion characteristics. The term micro-electrode refers to electrodes exhibiting convergent, steady-state, or quasi-steady-state diffusion on the characteristic time scale of the measurement. A micro-electrode is an electrode to which radial diffusion provides a significant alteration in the response function. Micro-electrodes, for example, can be dimensioned and positioned such that their primary impedance characteristics are characteristic of edge-to-edge kinetics, e.g., between the nearest edges of the fingers. More of this functionality will be discussed with respect to the example embodiments shown in the drawings.
One advantage of using the micro-electrodes is that these devices can be configured and operated to very rapidly reach a quasi-steady state of current flux at the electrodes, for example in as little as 0.50 to 3.25 seconds, or even in less than one-half second. This rapid acquisition of quasi-steady state allows for a faster and more accurate determination of analyte concentration. This is contrasted with prior art approaches which have, for example, estimated or projected the result based on readings taken before a quasi-steady state is reached.
A further advantage seen in some embodiments of the invention is that the quasi-steady state response to application of a DC signal is at a higher magnitude than the quasi-steady state in many prior art systems. This improves the signal-to-noise ratio of the signal, thus enabling the system to provide a more accurate result.
A still further advantage seen with the interdigitated arrays of electrode fingers used in some forms of the present invention is the dramatically increased electrode edge length that can be achieved within a given space.
Depending on the design, results can be derived in those systems with smaller samples, yet achieving the same quality of results as systems requiring larger samples.

It is noted that equations can be derived and used for the various micro-electrode configurations as would occur to those of ordinary skill in the art given this disclosure and the AC Excitation application, which was incorporated above by reference. It is also possible to use empirical measurements to directly determine the response function of the electrochemical structures present in each sensor design. It is noted that neither an analytic description of the response functions, nor attainment of a steady-state current are necessary for improved system performance.
General Description - Structure The present invention provides electrode structures and systems that are useful in a wide variety of biosensor devices. Described herein are exemplary test strip configurations that demonstrate the utility of the present invention. It will be appreciated, however, that the principles of the present invention are equally applicable in various other biosensor designs. The particular compositions, sizes and other characteristics of the basic biosensor components are not critical and are therefore not limiting.
With reference to FIG. 1, generally, strip 210 has a first end 211 for communication with driving circuitry and metering circuitry (not shown), while 5 end 218 is adapted to receive the bodily fluid in contact with electrodes as will be discussed herein. The driving circuitry provides a known current and/or potential through contacts 216 and monitors the current and/or voltage response over a period of time. The respective signals travel between contacts 216 and the electrodes (shown in FIGS. 2-14) via conductors 270,272, 274, and 276. These 10 conductors are made of any, or a combination, of a variety of conductive materials, including for example gold or carbon, as would be understood by those skilled in the art.
At end 218, notched fluid guide 214 is generally rectangular, with rectangular notch 148 cut therefrom, as can be seen in FIG. 2. Fluid guide 214 lies 15 on the substrate layer 212 (a polyimide or other material, as disclosed in the "Method of Making a Biosensor", US 2004/0194302, and provides an opening 251 (see FIG. 2) for the fluid to be drawn from edge 224 toward vent 262 by capillary action. Cover layer 250 lies on top of guide layer 236 and provides an upper containment for the fluid path defined in part by notch 248. These structures will 20 be discussed in more detail below.
Turning now to FIG. 2, with continuing reference to certain structures shown in FIG. 1, strip 210 includes substrate layer 212, reagent stripe 264, fluid guide 214, and cover layer 218. When assembled, passageway 248 is defined horizontally by inner notch surfaces 249, above by bottom surface 258 of cover layer 218, and below by reagent stripe 264 (which lies over electrode pair 284, but not over electrode pair 280) and electrode region 266 on upper substrate surface 232. During a testing operation, the fluid being tested enters passageway 248 through end 240 of fluid guide 214, past edges 254 and 224 of cover layer 218 and substrate 212, respectively. The fluid is drawn by capillary action into passageway 248, following a path extending away from edges 224 and 254, and toward vent 262 (see FIG. 1).
The capillary passageway provides a sample receiving chamber in which the measuring electrodes and associated reagent are contained, and the fluid sample containing the analyte contacts these components of the biosensor. It is a feature of the present invention that the dimensions of the capillary passageway may vary substantially. In one embodiment, the passageway is a volume that is 1000 gm wide, 100 gm high, and 2000 gm long. Other embodiments, and measurement of channels generally, are discussed in the Analyte Sensors application, referenced above. As the fluid travels along this path, it comes into contact with reagent and electrodes, as will be described in further detail below.
On substrate 212, contacts 278 are connected via traces 279 to electrodes 280. These electrodes 280 extend perpendicularly to the length of the substrate 212, parallel to edge 224 and to each other. In one preferred embodiment, electrodes 280 are rectangular, with a length sufficient to reach across the width of notch 248, a width of at least 50 gm, and a separation greater than about 50 m between nearest points thereof. In another preferred embodiment, electrodes 280 are about 100 gm wide, with a 100 m gap. In still other preferred embodiments, electrodes 280 are about 250 gm wide, with a 250 gm gap. Other configurations and dimensions will occur to those skilled in the art, and may be used in the present invention as required or desired given the design considerations for a particular strip and system.
Contacts 282 are connected via traces 277 to electrode pair 284.
Electrodes 284 each comprise multiple, parallel, elongated rectangles ("fingers"), each extending approximately parallel to edge 224 and perpendicular to the center line of notch 248, reaching at both ends beyond the width of notch 248. The rectangles connect at one end or the other to trace 274 or 276 in an alternating pattern to form an interdigitated series of fingers, which will be discussed in further detail below. In various embodiments, each rectangular finger in micro-electrode pair 284 is between about 5 and about 75 m in width, with a gap of about 5 to about 75 m between adjacent fingers.
The finger widths and the gaps between adjacent fingers are each preferably consistent across the width of notch 248.
Turning now to FIG. 3, with continuing reference to FIG. 2, a more magnified view of the electrode portion of strip 210 in FIG. 2 is shown. As discussed above, electrodes 280 run parallel to edge 224 of strip 210, and connect to their conductive traces 270 and 272 at opposite ends, forming electrode pair 266. Their nearest edges 281 are separated by a distance ("gap") indicated by reference number 286 that is substantially constant throughout their length. Similarly, interdigitated fingers 284 form an electrode pair 268, with alternating fingers connecting to conductive traces 274 and 276.
Turning to FIG. 4, strip 310 shows substrate layer 212, reagent stripe 364, notched fluid guide 214, and cover layer 218. In this embodiment, fluid entering capillary notch 348 defined by fluid guide 214 first encounters macro-electrodes 280. Macro-electrodes 280 are connected via conductors 379 to contacts 378 at end 368 of strip 310. Electrodes 280 are each, for example, about 250 m in width, and the gap between them is also about 250 m. Slightly further from strip end 366 is electrode pair 284, which is two electrodes of five fingers each, each finger on a side being connected via a conductor 377 to a contact 382 at strip end 368. Each finger in electrode pair 284 is a rectangle about 20 m in width, and each adjacent finger is separated from the next by a gap of about 20 m. Reagent stripe 364 covers electrode pair 280, but not electrode pair 284.
During a test, when the sample covers electrode pair 280, an AC signal is applied for a period of time to contacts 378. Similarly, for an overlapping period of time after the sample covers electrode pair 284, a DC signal is applied to contacts 382, and the electrical response between the electrodes in pair 284 is used to estimate the glucose concentration in the sample. The response of the sample between the fingers of electrode pair 280 is sensitive to the hematocrit of the sample, which along with a temperature value provided by a thermistor-based circuit provides a correction factor for the estimate obtained with electrodes 284. Note that this "correction factor" is not necessarily a multiplicative or additive factor, but may instead be used in a formula, in a lookup table, and/or in other ways to correct the estimate based on the temperature and the presence or absence of other materials in, or properties of, the sample as will be understood by those skilled in the art.
See, for example, the AC Excitation application, which was incorporated above by reference. In this embodiment, the volume of blood within capillary notch 348 sufficient to cover the measuring electrodes is about 130 nL.
An alternative embodiment is shown in FIG. 5 as strip 410. Substrate layer 212 is traced with two contacts 478, and is partially covered with reagent stripe 464 (over electrodes 480), notched fluid guide 214, and cover layer 218.
Contacts 478 are electrically connected via conductive traces 477 to both a first pair of electrodes 466 and a second pair of electrodes 468, one electrode from each pair being connected on each side to one of contacts 478. Note that in this embodiment the driver and meter circuitry (not shown) uses a single pair of contacts 478 to drive and measure response from both pairs of electrodes. Note further that the relative placements of micro-electrodes 484 and macro-electrodes 480 are reversed relative to the embodiment shown in FIG. 4. The macro-electrodes 480 are again, for example, about 250 m in width with a gap of about 250 m between them. Also, each electrode in micro-electrode pair 466 is made of five fingers that are interdigitated with the fingers in the other electrode of the pair. Each finger is again about 20 m in width with a gap of about 20 m between neighboring fingers.
In this embodiment, reagent stripe 464 covers electrode pair 468, but not electrode pair 466. When the sample covers electrode pair 466, the system uses an AC signal through that pair to determine correction factors for the analyte measurement. When the sample has covered electrode pair 468, an estimate of the analyte concentration is obtained using DC excitation methods known in the art, such as U.S. Patent Applications Number 09/530,171 and 10/264,891, PCT Application Number (WO) US98/27203, U.S. Patent No.
5,997,817, and the Electrochemical Biosensor Test Strip (reissue) application.
With the exemplary dimensions described above, the volume of the capillary cavity is about 130 nL.

Turning now to FIG. 6, it can be seen that strip 510 again comprises substrate layer 212, reagent stripe 564, notched fluid guide 214, and cover layer 218. In this embodiment, working electrode 581 lies between two counter electrode fingers 580, which are connected by one of the conductors 216 to the same contact. These electrodes 580 and 581 form a first electrode pair 480, and each of the three macro-electrode fingers in this electrode pair 480 is about 250 m wide, with a gap of about 250 m on either side of working electrode 581.

Second electrode pair 284 comprises two electrodes of six and seven fingers each, respectively, the fingers being interdigitated in an alternating pattern. Each finger is again about 20 pm wide, with a gap of about 20 m between adjacent fingers. In this embodiment, the reagent layer 564 covers both electrode pairs 480 and 284. The macro-electrode pair 480 provides Cottrell-like response, where current is proportional to the square root of the diffusion coefficient, while the micro-electrode pair 284 provides current that is directly proportional to the diffusion coefficient. The two responses, taken together, correct for environmental factors to yield an improved response. The volume of sample required for measurement in this embodiment is about 200 nL.

Another alternative embodiment is shown in FIG. 7. Strip 610 comprises substrate layer 212, reagent stripe 664, notched fluid guide 214, and cover layer 218. As in FIG. 6, the first electrode pair 572 comprises counter and working macro-electrodes 580 and 581, respectively, each about 250 m wide with a gap of about 250 m between them. In this embodiment, however, electrode pair 661 comprises two electrodes of three fingers each.

Each finger is about 50 gm in width, with a gap of about 50 gm between adjacent fingers.

The first electrode pair that the sample reaches (the macro-electrode pair 572) is used to obtain a hematocrit-based measurement using AC
5 excitation techniques. The second electrode pair (the micro-electrodes 661) is used to obtain a measurement that depends on the glucose in and hematocrit of the sample using DC excitation. The reagent stripe 664 covers only electrode pair 661, and a sample volume of about 200 nL is required to fill the capillary volume in the relevant region. The measurements are combined as parameters 10 to a formula based on the electrode configuration, reagent system, and other factors as would occur to one of skill in the art.
FIG. 8 provides yet another embodiment of the present invention.
Strip 710 comprises substrate layer 212, reagent stripe 364, notched fluid guide 214, and cover layer 218. In this embodiment, first electrode pair 366 15 comprises two macro-electrodes, each having a single rectangular finger, while second electrode pair 770 comprises two micro-electrodes, each micro-electrode having five fingers in an interdigitated pattern. The fingers in this embodiment are about 50 gm wide, with a gap of about 30 gm between them, and reagent stripe 364 covers second pair 770. The volume necessary to cover 20 the electrodes in the relevant portion of the capillary path is about 170 nL.
Turning now to FIG. 9, strip 810 comprises substrate layer 212, reagent stripe 364, notched fluid guide 214, and cover layer 218. A single pair of contacts 878 is connected via conductors 877 to both first electrode pair and second electrode pair 868. First electrode pair 866 comprises two single-25 finger macro-electrodes 884, while second electrode pair 868 comprises two micro-electrodes 880, each micro-electrode having five fingers in an interdigitated pattern. Each electrode in first electrode pair 866 is again about 250 gm wide, with a gap of about 250 gm between them. First electrode pair 866 is used to obtain a first measurement based on the hematocrit of the sample. Each finger of the second pair 868 is about 50 gm wide with a gap of about 30 m between adjacent fingers. When the sample covers second electrode pair 868, a DC signal is applied to contacts 878. The resulting impedance between electrodes 868 is used to obtain a second measurement based on the concentration of glucose in and hematocrit of the sample. That measurement is combined in a formula with the measurement obtained through first electrode pair 866 and a temperature signal from a thermistor (not shown) to obtain a corrected glucose concentration value. Reagent stripe 364 covers second electrode pair 868, and the required volume of sample is again about 170 nL.

FIG. 10 shows another alternative embodiment, strip 1010, which comprises substrate layer 212, reagent layer 1064, notched fluid guide 214, and cover layer 218. In this embodiment, the first electrode pair 1081 encountered by the sample includes working electrode 1071, a single-finger electrode. First electrode pair 1081 also includes counter electrode pair 1072, a two-finger electrode, with one finger on either side of working electrode 1071. Each finger in first electrode pair 1081 is about 250 4m wide, and a gap of about 250 m separates each counter electrode finger from the working electrode finger. Each of the electrodes (i.e., working electrode 1071 and counter electrode 1072) in first electrode pair 1081 is electrically connected via a conductive trace 216 to a contact 1067. The system driver connects to contacts 1067 to use the first electrode pair to obtain an estimated concentration of analyte in the sample.

The second electrode pair 1082 comprises two electrodes of five fingers each. These fingers are each about 50 m wide with a separation of about 30 m between them. Each electrode in the second pair connects to a conductive trace 216 to be electrically connected to a contact 1068, which contacts are used to drive and measure for correction factors such as hematocrit based on the analyte interaction with the second pair of electrodes.
The third electrode pair 1083 is also a micro-electrode configuration, with each of the two electrodes in the third pair 1083 having five fingers interdigitated with the five in the other electrode. Each finger is again about 50 gm wide, with a gap of about 30 gm between them. Each electrode in the third pair 1083 is connected via a conductive trace 216 to a contact 1069, and is driven via those contacts to detect sufficiency of the sample volume, based on the electrical response between those electrodes when the sample has reached a sufficient extent through the sample cavity 1048. Note that reagent layer 1064 covers upstream electrode pair 1081 in this embodiment. The sample cavity in this embodiment requires about 220 nL of sample fluid to cover all three electrode pairs.
Turning now to FIG. 11, strip 1110 comprises substrate layer 212, reagent stripe 1164, notched fluid guide layer 1114 with notch 1148, and cover layer 1118. The first electrode pair 1170 from the sample end 1166 of strip 1110 comprises two electrodes of five fingers each, where each finger is about gm wide, and a gap of about 20 gm separate each adjacent finger. This 15 electrode pair is used for determining the concentration of interferents such as hematocrit by using AC excitation and impedance measurement techniques.
For an example of these techniques, see the AC Excitation application, which was incorporated above by reference.
The second electrode pair 1171 from sample end 1166 of strip 1110 20 comprises two electrodes of three fingers each. Each finger is about 20 gm wide, and a gap of about 20 gm separating adjacent fingers. This system derives a temperature-compensated estimate of glucose concentration by applying AC or DC excitation techniques to this second electrode pair 1171.
The sample volume required to fill the capillary channel and cover the electrodes in this embodiment is about 69 nL.
Turning now to FIG. 12, strip 1210 comprises substrate 212, reagent stripe 1264, notched fluid guide 1114, and cover layer 1118. The first electrode pair 1266 from the sample end 1260 of strip 1210 includes two electrodes of five fingers each. This system uses the first pair of electrodes 1266 in strip 1210 to obtain one measurement based in substantial part on detection of interferents for combining with, another measurement, which is obtained using the second electrode pair 1268. The second electrode pair from the sample end of strip 1210 is electrode pair 1268, which includes two electrodes, each having three fingers, and the pair 1268 is covered by reagent layer 1264.
The fingers in second electrode pair 1268 are also about 20 m wide and are separated by a gap of about 20 m. This second electrode pair 1268 is used by the system to estimate the concentration of the analyte in the sample. While the first electrode pair 1266 implements AC techniques, the second electrode pair 1268 is driven by an AC or DC signal. Further downstream from the sample end (beyond the io second electrode pair 1268) is third electrode 1270, which is a single electrode finger about 20 m wide, connected via conductor 1274 to contact 1272. The AC
signal response between this third electrode 1270 and either the first electrode pair 1166 or the second electrode pair 1168 provides a sample sufficiency signal for the system. In a variation of this embodiment, third electrode 1270 operates as an is electrode in a circuit with second electrode pair 1168, for application of various detection and measurement techniques known in the art.
FIG. 13 shows strip 1410, which comprises substrate 212, reagent stripe 1464, fluid guide 1414 with notch 1448, and cover layer 1418. Substrate 212 has contacts 1469. The first set of electrodes 1170 from the sample end 1166 of strip 20 1410 includes two electrodes, each having five fingers. The fingers in electrodes 1170 are each about 20 Am wide, with a gap of about 10 Fcm separating adjacent interdigitated fingers.
Second set of electrodes 1171 comprises two electrodes having three fingers each. The fingers of electrodes 1171 are each about 20 m wide, with a 25 gap of about 10 p.m between adjacent, interdigitated fingers. While the first electrode pair 1170 is used by the system to determine the hematocrit of the sample and calculate a correction factor, an estimate of the glucose concentration is derived from the response of the second set of electrodes 1171 in the presence of the sample and reagent. The third pair of electrodes 1471 is two electrodes having two fingers each. In this embodiment, a potential is applied across the third pair 1471 until the sample reaches the pair, thus changing the impedance presented between the electrodes. The system can then conclude that the sample has sufficiently covered the first set 1170 and the second set 1171 of electrodes for an accurate analysis to be made. A
sample volume of about 63 nL is required to cover the three sets of electrodes in this exemplary embodiment.
FIG. 14 shows strip 1410, having substrate layer 212, reagent stripe 1464, notched fluid guide 1414 (with notch 1448), and cover layer 1418. The first electrode pair 1466 defines a first sensing zone 1476, and comprises two electrodes of five fingers each. The fingers are about 20 gm across, and include a gap of about 20 gm between interdigitated fingers. This pair 1466 is used to provide a response that reflects the hematocrit of the sample, allowing the system to correct the estimated concentration of glucose in the sample as determined by using the second pair of electrodes 1468. The second pair of electrodes 1468 defines second sensing zone 1478, and includes two electrodes having three fingers each. The finger sizes and gaps for second electrode pair 1468 are the same as those for first electrode pair 1466.
Second electrode pair 1468 is used to obtain correction factors for the concentration estimate obtained by the first electrode pair 1166, and uses AC/impedance measurement techniques.
Fig. 15 shows strip 1510, a variation of the strip in Fig. 11, where electrode pairs 1570 and 1571 and the layers covering them would be slightly modified. In particular, electrode pair 1570 comprises a working electrode having four fingers, each 50 j,m wide with a gap width of 20 j,m. The corresponding counter electrode in electrode pair 1570 has three fingers, also 50 gm wide. The second electrode pair 1571 comprises a working electrode having two fingers, each 100 gm wide, and a counter electrode having a single finger that is also 100 gm wide, with a gap width of 20 gm. In this embodiment, reagent 1564 would cover only electrode pair 1571, while coating 1565 would cover electrode pair 1570. Coating 1565 is a perm-selective, size-selective, ion-selective, or other coating that limits the portions or components of the sample that affect the measurement at electrode pair 1570, as are well known in the art. In variations on this embodiment, three or 5 more electrode pairs would be present, and each electrode pair would be covered with a different reagent or other coating, or combination of coatings to provide a corresponding number of measurements with different sensitivities, which measurements would be combined to determine the final measurement output. In other respects, except constants and functions derived 10 from the cell geometry and the selection of coating 1565 and reagent 1564, measurement occurs as described in relation to Fig. 11.
Various aspects of the described embodiments can be combined as desired or necessary, according to the design parameters and preferences for a given system. For example, there may be a one-to-one correspondence 15 between electrodes and contacts on a strip, as shown, for example, in FIG.
4.
Alternatively, all electrodes whose fingers are combined on the same side of a strip may be electrically connected to the same contact, as shown for example, in FIG. 5, providing a many-to-one relationship.
Furthermore, any design discussed herein can accommodate one or 20 more "dose sufficiency" electrodes downstream from those used to analyze the sample, as shown in FIGS. 11 and 14. Such dose sufficiency electrodes might comprise two or more electrodes, and the associated circuitry could determine whether the sample has reached those electrodes based on the impedance presented between them. Alternative embodiments include a single dose 25 sufficiency electrode, and the meter and driver circuitry use the impedance between it and a measuring electrode (working or counter-electrode, estimating or correcting pair) to detect the presence of the sample fluid in the space between those electrodes.
As previously described, the biosensor may similarly include a dose 30 detection electrode system that is comparable to the dose sufficiency electrode system except that it is located closer to the edge of the test strip, upstream of the measuring electrodes as the sample enters the test strip. Such a dose detection electrode system may include a single electrode that operates in combination with the measurement or other electrodes separately provided.
Alternatively, the dose detection electrode system may include a pair of electrodes which cooperate with one another to indicate when a sample fluid has bridged the gap between the dose detection electrodes. The dose detection electrodes are therefore seen to be analogous to the dose sufficiency electrodes in terms of operation, but differ as to the location of the electrodes in their upstream position relative to the measurement electrodes.
In other variations, a thermistor in the system is used to determine the temperature, which is used along with the hematocrit reading to correct the glucose estimate. In others, the second pair of electrodes provides a temperature-compensated glucose estimate using techniques known to those skilled in the art.

In still other variations, the pair of electrodes that the sample first encounters is a pair of macro-electrodes, while in others, it is a micro-electrode pair. In either case, each electrode comprises 1, 2, 3, 4, 5, or more fingers of appropriate dimension, all electrically connected both to each other and to a contact for communication with the meter/driver electronics.
Yet further variations use other combinations of measurements to achieve desired results. Generally, these variations apply electrical signals to two or more electrodes to obtain a corresponding number of response signals.
Because of the difference in the signal (AC versus DC, spectrum, amplitude, and the like), electrode shape or dimensions, reagent applied to the sample (or possibly the lack of reagent at one or more electrodes), and/or other differences, the response signals are sensitive to different combinations of analyte concentration and interferents. In one such example, a first response is correlated with the hematocrit of the sample, while a second response is correlated with a combination of hematocrit and concentration of glucose in the sample. In another such example, a first response is correlated with temperature, a second response is correlated with a combination of temperature and hematocrit, and a third response is correlated with a combination of temperature, hematocrit, and glucose. The result function(s) are likely to vary for each design, but they can be determined empirically by those skilled in the art without undue experimentation.
Those skilled in the art will appreciate that, while the embodiments herein have been described in terms of combining measurements, or taking a measurement and determining a correction factor, systems according to the present invention can use any suitable geometry and any appropriate technique to obtain and combine the plurality of measurements to achieve the final detection or measurement result. That is, those practicing this invention may use more or fewer electrodes, and any formula to combine readings that is suitable in light of the geometries, reagents, and other system design choices made in connection with that design.
As discussed in US 2005/0016844, accurate detection of analytes can be achieved in a smaller-volume strip-based system according to the present invention, without detrimental impact to the connector, than in prior art systems.
This allows a smaller sample to suffice for measurement, saving time and hassle for users of the system.
While the invention has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive in character, it being understood that only the preferred embodiments have been shown and described and that all changes and modifications that would occur to one skilled in the relevant art are desired to be protected.

Claims (20)

1. In a test strip that defines a capillary passageway, the passageway being dimensioned so as to induce movement of a sample of bodily fluid by capillary action along a predetermined path through the passageway, the improvement comprising:
a first set of electrodes in electrical communication with the passageway for obtaining a first measurement correlated with a concentration of an analyte in the sample; and a second set of electrodes in electrical communication with the passageway for obtaining a second measurement correlated with a property of the sample which affects the first measurement;
one of the set of electrodes comprising a pair of electrodes with parallel, interdigitated fingers, each electrode having at least two fingers, and each of the fingers being a first distance less than 50 µm from the nearest other finger in the one set of electrodes, and the other set of electrodes comprising a pair of macro electrodes having one finger each spaced apart a second distance of at least 50 µm.
2. The test strip of claim 1, in which the first set of electrodes comprises the pair of electrodes with parallel, interdigitated fingers.
3. The test strip of claim 1, in which the second set of electrodes comprises the pair of electrodes with parallel, interdigitated fingers.
4. The test strip of any one of claims 1 to 3, wherein each of the interdigitated fingers is at most 50 µm wide.
5. The test strip of any one of claims 1 to 4, wherein each of the fingers of the macro electrodes is at least 50 µm wide.
6. The test strip of any one of claims 1 to 5, wherein the first distance is a distance of at most 30 µm.
7. The test strip of any one of claims 1 to 6, wherein the second distance is a distance of at least 100 microns.
8. The test strip of any one of claims 1 to 7, and further comprising a third electrode set in electrical communication with the path for determining when the sample has entered a predetermined distance in the passage.
9. The test strip of claim 8, wherein the third electrode set includes at least one dose-detect electrode that is closer to an entrance of the passageway than both the first set of electrodes and the second set of electrodes.
10. The test strip of claim 9, wherein the third electrode set comprises a first dose-detect electrode and a second dose-detect electrode, both of which are closer to the entrance of the passage than both the first set of electrodes and the second set of electrodes.
11. The test strip of claim 8, wherein the third electrode set comprises a pair of sample sufficiency electrodes, both of which are farther from an entrance of the passage than both the first set of electrodes and the second set of electrodes.
12. The test strip of claim 11, and further comprising a fourth electrode set including at least one electrode that is closer to the entrance of the passageway than both the first set of electrodes and the second set of electrodes.
13. The test strip of any one of claims 1 to 12, wherein the first set of electrodes comprises a first electrode and a second electrode, and the second set of electrodes comprises a third electrode and a fourth electrode, the first electrode and the third electrode being electrically connected to each other, and the second electrode and the fourth electrode being electrically connected to each other.
14. The test strip of any one of claims 1 to 13, further comprising a reagent material over the first set of electrodes, where the reagent material combines with the sample of bodily fluid to produce a redox reaction.
15. The test strip of any one of claims 1 to 14, further comprising a reagent material over the second set of electrodes, where the reagent material combines with the sample of bodily fluid to produce a redox reaction.
16. The test strip of any one of claims 1 to 15, in which the passageway has a volume of at most 240 nL.
17. The test strip of any one of claims 1 to 16, in which the first and second sets of electrodes are positioned within the passageway such that the sample of bodily fluid moving by capillary action along the passageway will encounter the first and second sets of electrodes in a serial fashion.
18. A method of measuring a concentration of an analyte in a sample of bodily fluid, comprising:
providing the test strip in accordance with any one of claims 1 to 17;
obtaining a first response to an application of a first electrical signal to the first set of electrodes;
obtaining a second response to an application of a second electrical signal to the second set of electrodes; and using the first response and the second response to derive a measurement of the concentration of the analyte in the sample.
19. The method of claim 18, and further comprising, before the obtaining steps, detecting the application of the sample to the test strip.
20. The method of claim 18 or 19, and further comprising, before the obtaining steps, detecting the sufficiency of the volume of the sample.
CA2529300A 2003-06-20 2004-06-18 Devices and methods relating to electrochemical biosensors Expired - Fee Related CA2529300C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48024303P 2003-06-20 2003-06-20
US60/480,243 2003-06-20
PCT/US2004/019576 WO2004113910A1 (en) 2003-06-20 2004-06-18 Devices and methods relating to electrochemical biosensors

Publications (2)

Publication Number Publication Date
CA2529300A1 CA2529300A1 (en) 2004-12-29
CA2529300C true CA2529300C (en) 2011-10-18

Family

ID=33539277

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2529300A Expired - Fee Related CA2529300C (en) 2003-06-20 2004-06-18 Devices and methods relating to electrochemical biosensors
CA2529579A Expired - Fee Related CA2529579C (en) 2003-06-20 2004-06-18 Biosensor with multiple electrical functionalities

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA2529579A Expired - Fee Related CA2529579C (en) 2003-06-20 2004-06-18 Biosensor with multiple electrical functionalities

Country Status (13)

Country Link
US (3) US8506775B2 (en)
EP (3) EP3376223A1 (en)
JP (2) JP4489073B2 (en)
KR (2) KR100845163B1 (en)
CN (1) CN1839313B (en)
AU (1) AU2004250223B2 (en)
BR (1) BRPI0411695A (en)
CA (2) CA2529300C (en)
ES (1) ES2657627T3 (en)
HK (1) HK1096151A1 (en)
MX (1) MXPA05013747A (en)
PL (1) PL1642124T3 (en)
WO (2) WO2004113910A1 (en)

Families Citing this family (176)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8460243B2 (en) * 2003-06-10 2013-06-11 Abbott Diabetes Care Inc. Glucose measuring module and insulin pump combination
US7722536B2 (en) * 2003-07-15 2010-05-25 Abbott Diabetes Care Inc. Glucose measuring device integrated into a holster for a personal area network device
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US8535497B2 (en) * 2003-12-04 2013-09-17 Panasonic Corporation Method of measuring blood component, sensor used in the method, and measuring device
CN100432663C (en) * 2003-12-04 2008-11-12 松下电器产业株式会社 Hematocrit(hct) measuring method, sensor used for same, and measuring instrument
US9012232B2 (en) * 2005-07-15 2015-04-21 Nipro Diagnostics, Inc. Diagnostic strip coding system and related methods of use
US7501301B2 (en) * 2004-03-10 2009-03-10 The Board Of Trustees Of The Leland Stanford Junior University Low cost fabrication of microelectrode arrays for cell-based biosensors and drug discovery methods
KR101108381B1 (en) * 2004-04-19 2012-01-30 파나소닉 주식회사 Method for measuring blood components and biosensor and measuring instrument for use therein
US20060010098A1 (en) 2004-06-04 2006-01-12 Goodnow Timothy T Diabetes care host-client architecture and data management system
US7582262B2 (en) * 2004-06-18 2009-09-01 Roche Diagnostics Operations, Inc. Dispenser for flattened articles
US7556723B2 (en) * 2004-06-18 2009-07-07 Roche Diagnostics Operations, Inc. Electrode design for biosensor
US20060020192A1 (en) 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
JP5032321B2 (en) * 2004-08-31 2012-09-26 ライフスキャン・スコットランド・リミテッド Manufacturing method of automatic calibration sensor
US9351669B2 (en) 2009-09-30 2016-05-31 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
US7418285B2 (en) 2004-12-29 2008-08-26 Abbott Laboratories Analyte test sensor and method of manufacturing the same
US7545272B2 (en) 2005-02-08 2009-06-09 Therasense, Inc. RF tag on test strips, test strip vials and boxes
US7722537B2 (en) * 2005-02-14 2010-05-25 Optiscan Biomedical Corp. Method and apparatus for detection of multiple analytes
JP4631027B2 (en) * 2005-03-29 2011-02-16 独立行政法人産業技術総合研究所 IC tag mounted biosensor and its package
WO2006131697A2 (en) * 2005-06-10 2006-12-14 Hypoguard Limited Test system
WO2006133878A2 (en) * 2005-06-14 2006-12-21 Roche Diagnostics Gmbh Methods and devices for controlling the impact of short circuit faults on co-planar electrochemical sensors
US8999125B2 (en) 2005-07-15 2015-04-07 Nipro Diagnostics, Inc. Embedded strip lot autocalibration
US7955856B2 (en) * 2005-07-15 2011-06-07 Nipro Diagnostics, Inc. Method of making a diagnostic test strip having a coding system
US20070017824A1 (en) * 2005-07-19 2007-01-25 Rippeth John J Biosensor and method of manufacture
GB0514728D0 (en) 2005-07-19 2005-08-24 Hypoguard Ltd Biosensor and method of manufacture
GB0518527D0 (en) * 2005-09-10 2005-10-19 Oxford Biosensors Ltd Scaling factor for an output of an electrochemical cell
KR100680267B1 (en) * 2005-09-16 2007-02-08 주식회사 인포피아 Biosensor had the identification information and reading apparatus for the identification information recorded a biosensor
DK1949101T3 (en) * 2005-11-14 2013-06-10 Bayer Healthcare Llc Assay Sensor Reagent with Cellulose Polymers
WO2007057473A1 (en) * 2005-11-21 2007-05-24 Kurt Hoffmann Method for the detection of decomposition processes
US7741142B2 (en) * 2005-11-22 2010-06-22 Hewlett-Packard Development Company, L.P. Method of fabricating a biosensor
EP1793228A1 (en) * 2005-12-05 2007-06-06 F. Hoffmann-La Roche AG Method to give acoustically an information in an analytical system
TWI335428B (en) * 2005-12-23 2011-01-01 Apex Biotechnology Corp Electrochemical test strip
JP4735833B2 (en) * 2006-01-13 2011-07-27 セイコーエプソン株式会社 Biochip and biosensor
EP1813937A1 (en) * 2006-01-25 2007-08-01 Roche Diagnostics GmbH Electrochemical biosensor analysis system
US8940246B2 (en) * 2006-03-13 2015-01-27 Nipro Diagnostics, Inc. Method and apparatus for coding diagnostic meters
US8388906B2 (en) * 2006-03-13 2013-03-05 Nipro Diagnostics, Inc. Apparatus for dispensing test strips
US11559810B2 (en) 2006-03-13 2023-01-24 Trividia Health, Inc. Method and apparatus for coding diagnostic meters
US8388905B2 (en) * 2006-03-13 2013-03-05 Nipro Diagnostics, Inc. Method and apparatus for coding diagnostic meters
US7887682B2 (en) 2006-03-29 2011-02-15 Abbott Diabetes Care Inc. Analyte sensors and methods of use
JP5027455B2 (en) * 2006-06-29 2012-09-19 ユニ・チャーム株式会社 Excrement detection sensor
US20080020452A1 (en) * 2006-07-18 2008-01-24 Natasha Popovich Diagnostic strip coding system with conductive layers
US8945369B2 (en) * 2006-07-26 2015-02-03 Panasonic Healthcare Co., Ltd. Biosensor measurement system and measurement method
US20080083618A1 (en) * 2006-09-05 2008-04-10 Neel Gary T System and Methods for Determining an Analyte Concentration Incorporating a Hematocrit Correction
TWI317015B (en) * 2006-10-02 2009-11-11 Eps Bio Technology Corp Biosensing device
EP2082222B1 (en) 2006-10-05 2012-11-21 Lifescan Scotland Limited Systems and methods for determining a substantially hematocrit independent analyte concentration
US9046480B2 (en) 2006-10-05 2015-06-02 Lifescan Scotland Limited Method for determining hematocrit corrected analyte concentrations
US20080101984A1 (en) * 2006-10-31 2008-05-01 Selwayan Saini Method for determining an analyte in a bodily fluid sample
US20080100689A1 (en) * 2006-10-31 2008-05-01 Selwayan Saini Method for manufacturing an analytical test strip with an electroluminescent component
US7740801B2 (en) * 2006-10-31 2010-06-22 Lifescan Scotland Limited System for determination of an analyte in a bodily fluid sample that includes an electroluminescent component
US20080101986A1 (en) * 2006-10-31 2008-05-01 Selwayan Saini Analytical test strip with electroluminescent module
US20080101987A1 (en) * 2006-10-31 2008-05-01 Selwayan Saini Analytical test strip with electroluminescent lamp
CA2608609A1 (en) * 2006-10-31 2008-04-30 Lefescan Scotland Limited Analytical test strip with electroluminescent lamp
US20090288964A1 (en) * 2006-12-13 2009-11-26 Sung-Kwon Jung Biosensor with coded information and method for manufacturing the same
US8409424B2 (en) * 2006-12-19 2013-04-02 Apex Biotechnology Corp. Electrochemical test strip, electrochemical test system, and measurement method using the same
TW200829918A (en) * 2007-01-03 2008-07-16 Hmd Biomedical Inc Identification notation-containing test strip and test instrument thereof
US20080237040A1 (en) * 2007-03-27 2008-10-02 Paul Wessel Test strip and monitoring device
US8460524B2 (en) 2007-04-18 2013-06-11 Nipro Diagnostics, Inc. System and methods of chemistry patterning for a multiple well biosensor
US8597190B2 (en) 2007-05-18 2013-12-03 Optiscan Biomedical Corporation Monitoring systems and methods with fast initialization
GB0711780D0 (en) * 2007-06-18 2007-07-25 Oxford Biosensors Ltd Electrochemical data rejection methodology
US8206564B2 (en) * 2007-07-23 2012-06-26 Bayer Healthcare Llc Biosensor calibration system
WO2009020690A1 (en) * 2007-08-06 2009-02-12 Bayer Healthcare Llc System and method for automatic calibration
WO2009051901A2 (en) 2007-08-30 2009-04-23 Pepex Biomedical, Llc Electrochemical sensor and method for manufacturing
WO2009032760A2 (en) 2007-08-30 2009-03-12 Pepex Biomedical Llc Electrochmical sensor and method for manufacturing
DE102007041395A1 (en) * 2007-08-31 2009-03-05 Thüringisches Institut für Textil- und Kunststoff-Forschung e.V. UV dosimeter with self-supply and warning signal (display)
US7943022B2 (en) * 2007-09-04 2011-05-17 Lifescan, Inc. Analyte test strip with improved reagent deposition
TW200914826A (en) * 2007-09-21 2009-04-01 Apex Biotechnology Corp Electrochemical quantitative analysis system and method for the same
ES2400966T3 (en) * 2007-09-22 2013-04-15 F. Hoffmann-La Roche Ag Analysis system to determine the concentration of an analyte in a body fluid
CA2984510C (en) * 2007-09-24 2020-06-09 Ascensia Diabetes Care Holdings Ag Multi-region and potential test sensors, methods, and systems
CN101842493B (en) * 2007-10-31 2013-06-19 霍夫曼-拉罗奇有限公司 Electrical patterns for biosensor and method of making
US8241488B2 (en) 2007-11-06 2012-08-14 Bayer Healthcare Llc Auto-calibrating test sensors
US7809512B2 (en) * 2007-11-11 2010-10-05 Bayer Healthcare Llc Biosensor coding system
WO2009076263A1 (en) 2007-12-10 2009-06-18 Bayer Healthcare Llc An auto-calibrating test sensor and method of making the same
JP4944083B2 (en) 2007-12-12 2012-05-30 パナソニック株式会社 Biological sample measuring specimen and biological sample measuring device
US20090205399A1 (en) * 2008-02-15 2009-08-20 Bayer Healthcare, Llc Auto-calibrating test sensors
US20090223287A1 (en) * 2008-03-04 2009-09-10 Visgeneer, Inc. Bio-Monitoring System and Methods of Use Thereof
JP2009250806A (en) 2008-04-07 2009-10-29 Panasonic Corp Biosensor system, sensor chip and measuring method of concentration of analyte in blood sample
US8032321B2 (en) * 2008-07-15 2011-10-04 Bayer Healthcare Llc Multi-layered biosensor encoding systems
US8465977B2 (en) * 2008-07-22 2013-06-18 Roche Diagnostics Operations, Inc. Method and apparatus for lighted test strip
DE102008038457B4 (en) * 2008-08-20 2013-10-24 Advanced Display Technology Ag Device for fluidic display
CN102227636A (en) * 2008-09-30 2011-10-26 梅纳伊医疗科技有限公司 Sample measurement system
US8424763B2 (en) * 2008-10-07 2013-04-23 Bayer Healthcare Llc Method of forming an auto-calibration circuit or label
KR101003077B1 (en) * 2008-10-16 2010-12-21 세종공업 주식회사 Electrochemical biosensor structure and measuring method using the same
TW201018903A (en) * 2008-11-07 2010-05-16 Yuan-Soon Ho Inspection device and inspection method used for measuring substance concentration inside stomach
CN102209893B (en) * 2008-11-28 2013-06-26 松下电器产业株式会社 Sensor chip, biosensor system, method for measuring temperature of biological sample, method for measuring temperature of blood sample, and method for measuring concentration of analyte in blood sample
KR101047363B1 (en) 2008-12-22 2011-07-07 한국전자통신연구원 Multi-function sensor capable of self-generation and its manufacturing method
EP3450969A1 (en) * 2009-01-30 2019-03-06 PHC Holdings Corporation Sensor chip for measuring temperature of biological sample and concentration of analyte in the biological sample
US9134221B2 (en) 2009-03-10 2015-09-15 The Regents Of The University Of California Fluidic flow cytometry devices and particle sensing based on signal-encoding
WO2011003035A2 (en) 2009-07-02 2011-01-06 Dexcom, Inc. Analyte sensor
KR101420773B1 (en) 2009-07-15 2014-07-17 주성엔지니어링(주) Electro-optic device and method for manufacturing the same
US9091676B2 (en) 2010-06-09 2015-07-28 Optiscan Biomedical Corp. Systems and methods for measuring multiple analytes in a sample
US20110048972A1 (en) * 2009-08-31 2011-03-03 Lifescan Scotland Limited Multi-analyte test strip with shared counter/reference electrode and inline electrode configuration
CN101670998B (en) * 2009-09-16 2011-10-26 哈尔滨工业大学 Point-plane electrode system and method for micro-fluid drive by using the system
KR100980316B1 (en) * 2009-12-09 2010-09-06 동진메디칼 주식회사 Strip having thermal compensating function and method for measuring blood sugar using it
TWI440853B (en) * 2009-12-14 2014-06-11 Taidoc Technology Corp Electrochemical biosensing test strip, biosensing meter, system and measuring method for analyte measurement incorporating a hematocrit correction
EP2528510A4 (en) * 2010-01-25 2013-06-19 Einstein Coll Med Device for collecting and analyzing migratory tumor cells
US8529742B2 (en) * 2010-02-24 2013-09-10 Matthew K. Musho Electrochemical sensor with controlled variation of working electrode
GB201005357D0 (en) 2010-03-30 2010-05-12 Menai Medical Technologies Ltd Sampling plate
GB201005359D0 (en) 2010-03-30 2010-05-12 Menai Medical Technologies Ltd Sampling plate
US8940141B2 (en) 2010-05-19 2015-01-27 Lifescan Scotland Limited Analytical test strip with an electrode having electrochemically active and inert areas of a predetermined size and distribution
WO2012028697A1 (en) 2010-09-01 2012-03-08 Eth Zürich, Institute Of Molecular Biology And Biophysics Affinity purification system based on donor strand complementation
BR112013005720A2 (en) * 2010-09-09 2019-09-24 S E A Medical Systems Inc sensor for immittance spectroscopy, immittance spectroscopy systems and for accumulating and identifying drug residues, methods of determining the identity and / or concentration of a drug, for accumulating and identifying drug residue, for determining the identity and concentration of a drug and to precisely and automatically supply a drug, and a fully automated medical system
US8431408B2 (en) 2010-10-15 2013-04-30 Roche Diagnostics Operations, Inc. Handheld diabetes managing device with light pipe for enhanced illumination
KR101885936B1 (en) 2010-10-21 2018-09-10 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 Microfluidics with Wirelessly Powered Electronic Circuits
WO2012080479A1 (en) * 2010-12-17 2012-06-21 Sanofi-Aventis Deutschland Gmbh Bodily fluid analysis device
WO2012106972A1 (en) * 2011-02-08 2012-08-16 Beijing Metis Biomed Ltd Blood glucose sensor
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
GB2489504A (en) * 2011-03-31 2012-10-03 Sapient Sensors A device for identifying the presence of a specific target molecule or biomarker by sensing an electrical property
CA2856380C (en) * 2011-11-22 2020-05-12 Siemens Healthcare Diagnostics Inc. Interdigitated array and method of manufacture
KR101466222B1 (en) * 2012-06-01 2014-12-01 주식회사 아이센스 Electrochemical biosensor with improved accuracy
US8877023B2 (en) 2012-06-21 2014-11-04 Lifescan Scotland Limited Electrochemical-based analytical test strip with intersecting sample-receiving chambers
US9128038B2 (en) 2012-06-21 2015-09-08 Lifescan Scotland Limited Analytical test strip with capillary sample-receiving chambers separated by a physical barrier island
JP5947909B2 (en) * 2012-10-10 2016-07-06 パナソニックヘルスケアホールディングス株式会社 Biological information measuring device
JP6396911B2 (en) 2012-10-15 2018-09-26 ナノセレクト バイオメディカル, インコーポレイテッド System, apparatus and method for sorting particles
BR112015012958B1 (en) 2012-12-03 2022-03-15 Pepex Biomedical, Inc Sensor module to detect an analyte in a blood sample
TWI493186B (en) * 2013-02-08 2015-07-21 Hmd Biomedical Inc Test strip, detecting device and detection method
TWI477772B (en) 2013-02-25 2015-03-21 Apex Biotechnology Corp Electrode strip and sensor strip and system thereof
CN104034780B (en) * 2013-03-06 2016-07-06 五鼎生物技术股份有限公司 Electrode test piece and sensing test piece and there is the sensing system of correction Hematocrit
US9157883B2 (en) * 2013-03-07 2015-10-13 Lifescan Scotland Limited Methods and systems to determine fill direction and fill error in analyte measurements
US9445445B2 (en) 2013-03-14 2016-09-13 Dexcom, Inc. Systems and methods for processing and transmitting sensor data
EP2972268B1 (en) 2013-03-15 2017-05-24 Roche Diabetes Care GmbH Methods of failsafing electrochemical measurements of an analyte as well as devices, apparatuses and systems incorporating the same
WO2014140177A2 (en) 2013-03-15 2014-09-18 Roche Diagnostics Gmbh Methods of detecting high antioxidant levels during electrochemical measurements and failsafing an analyte concentration therefrom as well as devices, apparatuses and systems incorporting the same
WO2014140164A1 (en) 2013-03-15 2014-09-18 Roche Diagnostics Gmbh Methods of using information from recovery pulses in electrochemical analyte measurements as well as devices, apparatuses and systems incorporating the same
CN105164523B (en) 2013-03-15 2017-09-12 豪夫迈·罗氏有限公司 Scale the method for the data for constructing biology sensor algorithm and merge the unit and system of methods described
EP2781919A1 (en) 2013-03-19 2014-09-24 Roche Diagniostics GmbH Method / device for generating a corrected value of an analyte concentration in a sample of a body fluid
EP2994536B1 (en) 2013-05-08 2017-06-14 Roche Diabetes Care GmbH Stabilization of enzymes by nicotinic acid
JP6521948B2 (en) * 2013-06-10 2019-05-29 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Method and system for detecting an analyte in body fluid
US9529503B2 (en) * 2013-06-27 2016-12-27 Lifescan Scotland Limited Analyte-measurement system recording user menu choices
CN104330444A (en) * 2013-07-22 2015-02-04 财团法人多次元智能It融合系统研究团 Near-field-communication or rfid based electrochemical biosensor and method for an ingredient measurement using thereof
EP3042180A4 (en) * 2013-09-05 2017-04-05 Empire Technology Development LLC Cell culturing and tracking with oled arrays
US9383332B2 (en) 2013-09-24 2016-07-05 Lifescan Scotland Limited Analytical test strip with integrated battery
US9571904B2 (en) 2013-11-21 2017-02-14 Ge Healthcare Bio-Sciences Ab Systems and methods for status indication in a single-use biomedical and bioprocess system
WO2015078899A1 (en) 2013-11-27 2015-06-04 Roche Diagnostics Gmbh Composition comprising up-converting phosphors for detecting an analyte
GB201321430D0 (en) 2013-12-04 2014-01-15 Spd Swiss Prec Diagnostics Gmbh Assay device
KR101552912B1 (en) * 2013-12-24 2015-09-15 (주) 파루 Cyclic Voltammetry Tag and its Fabricating Method
KR101552777B1 (en) * 2013-12-31 2015-09-14 재단법인 다차원 스마트 아이티 융합시스템 연구단 Biosensor package and packaging method thereof
KR101559215B1 (en) * 2013-12-31 2015-10-15 재단법인 다차원 스마트 아이티 융합시스템 연구단 Biosensor package and packaging method thereof
KR101585313B1 (en) * 2014-01-06 2016-01-13 재단법인 다차원 스마트 아이티 융합시스템 연구단 Biosensor and sample inflow sensing method based on capacitance
US9897566B2 (en) 2014-01-13 2018-02-20 Changsha Sinocare Inc. Disposable test sensor
US10114008B2 (en) 2014-01-21 2018-10-30 Empire Technology Development Llc Methods and devices for high throughput screening of conditions affecting stem cell differentiation
US9939401B2 (en) 2014-02-20 2018-04-10 Changsha Sinocare Inc. Test sensor with multiple sampling routes
EP2927319A1 (en) 2014-03-31 2015-10-07 Roche Diagnostics GmbH High load enzyme immobilization by crosslinking
CN106164054B (en) 2014-04-14 2019-05-07 豪夫迈·罗氏有限公司 Azophenlyene mediates agent
US9370401B2 (en) * 2014-05-12 2016-06-21 Philip W. Sayles Millimeter-sized recognition signal badge and identification system for accurately discerning and sorting among similar kinds, shapes, and sizes of surgical instruments
US10036709B2 (en) * 2014-05-20 2018-07-31 Roche Diabetes Care, Inc. BG meter illuminated test strip
WO2015187959A1 (en) 2014-06-04 2015-12-10 Pepex Biomedical, Inc. Electrochemical sensors and methods for making electrochemical sensors using advanced printing technology
KR101923797B1 (en) * 2014-06-05 2018-11-29 에프. 호프만-라 로슈 아게 Electrode arrangements for test element integrity
KR102247666B1 (en) * 2014-08-22 2021-05-03 삼성전자주식회사 An electrochemical biosensor
JP6659669B2 (en) 2014-08-22 2020-03-04 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Redox indicator
JP6639479B2 (en) 2014-08-25 2020-02-05 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Interference-compensated two-electrode test strip
BR112017004896B8 (en) * 2014-09-12 2024-01-02 Trividia Health Inc System for measuring sample property in liquid, diagnostic test strip and method for measuring glucose concentration in blood sample
WO2016073395A1 (en) * 2014-11-03 2016-05-12 Roche Diabetes Care, Inc. Electrode arrangements for electrochemical test elements and methods of use thereof
JP6410308B2 (en) * 2014-12-12 2018-10-24 国立大学法人東北大学 Sensor chip, detection system, and detection method
CN107250792A (en) * 2014-12-31 2017-10-13 三伟达保健公司 Glucose test strip with interference correction
CN104730135A (en) * 2015-04-07 2015-06-24 天津理工大学 Non-enzymatic glucose sensor for modifying screen-printed electrode based on nano composite material
FR3035220A1 (en) * 2015-04-20 2016-10-21 Commissariat Energie Atomique "ELECTRONIC DEVICE FOR MEASURING AT LEAST ONE ELECTRICAL CHARACTERISTIC OF AN OBJECT"
EP3088880B1 (en) * 2015-04-28 2024-04-24 Industrial Technology Research Institute Methods for measuring analyte concentration
JP6607437B2 (en) * 2015-06-26 2019-11-20 国立研究開発法人産業技術総合研究所 Biosensor
US11143645B2 (en) 2015-12-17 2021-10-12 Polymer Technology Systems, Inc. Systems and methods for a versatile electrochemical test strip that may include one or more assays for different analytes in the same test strip
WO2017106560A1 (en) * 2015-12-18 2017-06-22 Trividia Health, Inc. In-vitro sensor using a tetrapolar impedance measurement
WO2017145420A1 (en) * 2016-02-25 2017-08-31 パナソニックヘルスケアホールディングス株式会社 Biosensor
ES2837390T3 (en) 2016-03-31 2021-06-30 Dexcom Inc Analyte monitoring system
CN109804240A (en) 2016-10-05 2019-05-24 豪夫迈·罗氏有限公司 Detection reagent and electrode arrangement and its application method for multiple analyte diagnostic test element
GB2555855A (en) * 2016-11-14 2018-05-16 Sumitomo Chemical Co Short-range radio frequency communication device
CN110140046A (en) * 2016-11-25 2019-08-16 普和希控股公司 The method for measuring the ingredient of organism sample
US11371957B2 (en) * 2017-06-30 2022-06-28 Abbott Diabetes Care Inc. Method and apparatus for analyte detection using an electrochemical biosensor
WO2019035077A1 (en) 2017-08-17 2019-02-21 Abbott Point Of Care Inc. Devices, systems, and methods for performing optical assays
EP3669179B1 (en) * 2017-08-17 2023-07-19 Abbott Point Of Care Inc Systems for performing optical and electrochemical assays
EP3707495A1 (en) * 2017-08-17 2020-09-16 Abbott Point of Care Inc. Techniques for performing optical and electrochemical assays with universal circuitry
EP3710790A4 (en) * 2017-11-17 2021-01-20 Siemens Healthcare Diagnostics, Inc. Sensor assembly and method of using same
WO2019166394A1 (en) 2018-02-28 2019-09-06 F. Hoffmann-La Roche Ag Biocompatibility coating for continuous analyte measurement
CN110412099B (en) * 2018-04-30 2022-05-13 财团法人工业技术研究院 Biosensor and bioassay method
CN111202506A (en) * 2018-11-21 2020-05-29 浙江清华柔性电子技术研究院 Fluid detection device, preparation method thereof and blood detection device in blood vessel
CN109752423B (en) * 2019-01-21 2022-03-11 上海交通大学 Uric acid sensor based on organic thin film transistor array and control method
CN111189883A (en) * 2020-01-17 2020-05-22 杭州瑞盟科技有限公司 Blood sugar detection system and method
CN111239229B (en) * 2020-02-24 2023-04-11 江苏鱼跃医疗设备股份有限公司 Dual-channel electrochemical biosensor and method for measuring heme concentration
US20210277439A1 (en) * 2020-03-04 2021-09-09 Yu-Chung Norman Cheng Malaria detection method and device
US20220057358A1 (en) * 2020-08-20 2022-02-24 Polymer Technology Systems, Inc. Systems and Methods for a Test Strip Calibrator Simulating an Electrochemical Test Strip

Family Cites Families (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228542A1 (en) 1982-07-30 1984-02-02 Siemens AG, 1000 Berlin und 8000 München METHOD FOR DETERMINING THE CONCENTRATION OF ELECTROCHEMICALLY IMPLEMENTABLE SUBSTANCES
US4713165A (en) * 1986-07-02 1987-12-15 Ilex Corporation Sensor having ion-selective electrodes
DE68924026T3 (en) * 1988-03-31 2008-01-10 Matsushita Electric Industrial Co., Ltd., Kadoma BIOSENSOR AND ITS MANUFACTURE.
US5312762A (en) * 1989-03-13 1994-05-17 Guiseppi Elie Anthony Method of measuring an analyte by measuring electrical resistance of a polymer film reacting with the analyte
JPH02310457A (en) * 1989-05-26 1990-12-26 Matsushita Electric Ind Co Ltd Biosensor
JPH0820412B2 (en) 1990-07-20 1996-03-04 松下電器産業株式会社 Quantitative analysis method and device using disposable sensor
JPH0526838A (en) * 1991-07-23 1993-02-02 Aloka Co Ltd Fine platinum electrode
US5264103A (en) * 1991-10-18 1993-11-23 Matsushita Electric Industrial Co., Ltd. Biosensor and a method for measuring a concentration of a substrate in a sample
JP2658769B2 (en) * 1991-10-21 1997-09-30 松下電器産業株式会社 Biosensor
JP2541081B2 (en) * 1992-08-28 1996-10-09 日本電気株式会社 Biosensor and method of manufacturing and using biosensor
US5385846A (en) 1993-06-03 1995-01-31 Boehringer Mannheim Corporation Biosensor and method for hematocrit determination
JP3035352B2 (en) * 1993-08-24 2000-04-24 メトリカ・インコーポレーテッド New disposable electronic test device
KR0151203B1 (en) 1994-12-08 1998-12-01 이헌조 Multi-electrode type biosensor
US5677546A (en) * 1995-05-19 1997-10-14 Uniax Corporation Polymer light-emitting electrochemical cells in surface cell configuration
US5698083A (en) * 1995-08-18 1997-12-16 Regents Of The University Of California Chemiresistor urea sensor
US5766789A (en) * 1995-09-29 1998-06-16 Energetics Systems Corporation Electrical energy devices
AUPN661995A0 (en) * 1995-11-16 1995-12-07 Memtec America Corporation Electrochemical cell 2
US5897522A (en) * 1995-12-20 1999-04-27 Power Paper Ltd. Flexible thin layer open electrochemical cell and applications of same
US5830341A (en) * 1996-01-23 1998-11-03 Gilmartin; Markas A. T. Electrodes and metallo isoindole ringed compounds
US6241862B1 (en) 1996-02-14 2001-06-05 Inverness Medical Technology, Inc. Disposable test strips with integrated reagent/blood separation layer
GB2310493B (en) 1996-02-26 2000-08-02 Unilever Plc Determination of the characteristics of fluid
JP3460183B2 (en) * 1996-12-24 2003-10-27 松下電器産業株式会社 Biosensor
JP3394262B2 (en) * 1997-02-06 2003-04-07 セラセンス、インク. Small volume in vitro analyte sensor
JPH1164271A (en) * 1997-08-18 1999-03-05 Nagoyashi Current amplification type oxyzen sensor
US6054039A (en) 1997-08-18 2000-04-25 Shieh; Paul Determination of glycoprotein and glycosylated hemoglobin in blood
DE19753847A1 (en) 1997-12-04 1999-06-10 Roche Diagnostics Gmbh Analytical test element with capillary channel
US6036924A (en) * 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US5997817A (en) 1997-12-05 1999-12-07 Roche Diagnostics Corporation Electrochemical biosensor test strip
US7390667B2 (en) * 1997-12-22 2008-06-24 Roche Diagnostics Operations, Inc. System and method for analyte measurement using AC phase angle measurements
US6274326B1 (en) 1998-02-17 2001-08-14 Umm Electronics, Inc. Method and apparatus for detecting proper strip insertion into an optical reflectance meter
AU4215999A (en) * 1998-06-01 1999-12-20 Roche Diagnostics Corporation Redox reversible imidazole-osmium complex conjugates
JP2000019147A (en) * 1998-07-01 2000-01-21 Nok Corp Reaction product measuring device
DE19844500A1 (en) 1998-09-29 2000-03-30 Roche Diagnostics Gmbh Process for the photometric evaluation of test elements
US6338790B1 (en) * 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
GB9825992D0 (en) 1998-11-28 1999-01-20 Moorlodge Biotech Ventures Lim Electrochemical sensor
US6561978B1 (en) * 1999-02-12 2003-05-13 Cygnus, Inc. Devices and methods for frequent measurement of an analyte present in a biological system
WO2000052457A1 (en) * 1999-03-02 2000-09-08 Helix Biopharma Corporation Card-based biosensor device
US6287451B1 (en) * 1999-06-02 2001-09-11 Handani Winarta Disposable sensor and method of making
US6193873B1 (en) * 1999-06-15 2001-02-27 Lifescan, Inc. Sample detection to initiate timing of an electrochemical assay
CA2305922C (en) * 1999-08-02 2005-09-20 Bayer Corporation Improved electrochemical sensor design
US7276146B2 (en) * 2001-11-16 2007-10-02 Roche Diagnostics Operations, Inc. Electrodes, methods, apparatuses comprising micro-electrode arrays
US6662439B1 (en) 1999-10-04 2003-12-16 Roche Diagnostics Corporation Laser defined features for patterned laminates and electrodes
US6767440B1 (en) 2001-04-24 2004-07-27 Roche Diagnostics Corporation Biosensor
US6319719B1 (en) 1999-10-28 2001-11-20 Roche Diagnostics Corporation Capillary hematocrit separation structure and method
US6923894B2 (en) * 1999-11-11 2005-08-02 Apex Biotechnology Corporation Biosensor with multiple sampling ways
US6331438B1 (en) * 1999-11-24 2001-12-18 Iowa State University Research Foundation, Inc. Optical sensors and multisensor arrays containing thin film electroluminescent devices
US6603548B2 (en) * 1999-12-03 2003-08-05 Sciperio, Inc. Biosensor
US20020090649A1 (en) * 1999-12-15 2002-07-11 Tony Chan High density column and row addressable electrode arrays
US6413395B1 (en) * 1999-12-16 2002-07-02 Roche Diagnostics Corporation Biosensor apparatus
KR100776980B1 (en) 2000-03-09 2007-11-21 클리니컬 어낼리시스 코포레이션 Medical diagnostic system
US6612111B1 (en) * 2000-03-27 2003-09-02 Lifescan, Inc. Method and device for sampling and analyzing interstitial fluid and whole blood samples
US20020036291A1 (en) * 2000-06-20 2002-03-28 Parker Ian D. Multilayer structures as stable hole-injecting electrodes for use in high efficiency organic electronic devices
US7008524B2 (en) * 2000-10-03 2006-03-07 Hrl Laboratories, Llc Sensors with variable response behavior
ATE314822T1 (en) * 2000-10-10 2006-02-15 Microchips Inc MICROCHIP RESERVOIR DEVICES WITH WIRELESS TRANSMISSION OF ENERGY AND DATA
US7575939B2 (en) * 2000-10-30 2009-08-18 Sru Biosystems, Inc. Optical detection of label-free biomolecular interactions using microreplicated plastic sensor elements
US6540890B1 (en) * 2000-11-01 2003-04-01 Roche Diagnostics Corporation Biosensor
JP4627912B2 (en) * 2000-11-09 2011-02-09 パナソニック株式会社 Biosensor
EP2096437B1 (en) * 2000-11-30 2014-11-19 Panasonic Healthcare Co., Ltd. Biosensor for quantifying substrate
JP2003156469A (en) * 2001-11-22 2003-05-30 Matsushita Electric Ind Co Ltd Biosensor, measuring device for biosensor and quantitative determination method of substrate
US6793802B2 (en) 2001-01-04 2004-09-21 Tyson Bioresearch, Inc. Biosensors having improved sample application and measuring properties and uses thereof
CN102012389B (en) 2001-01-17 2013-04-10 爱科来株式会社 Quantitative analyzing method and quantitative analyzer using sensor
EP1281955B1 (en) 2001-04-16 2013-06-05 Panasonic Corporation Biosensor
WO2002094092A1 (en) * 2001-05-18 2002-11-28 Polymer Technology Systems, Inc. Body fluid test apparatus with detachably mounted portable tester
US20020177763A1 (en) 2001-05-22 2002-11-28 Burns David W. Integrated lancets and methods
US7473398B2 (en) 2001-05-25 2009-01-06 Roche Diagnostics Operations, Inc. Biosensor
DE60229476D1 (en) * 2001-05-29 2008-12-04 Matsushita Electric Ind Co Ltd Biosensor
US7044911B2 (en) * 2001-06-29 2006-05-16 Philometron, Inc. Gateway platform for biological monitoring and delivery of therapeutic compounds
US6814844B2 (en) 2001-08-29 2004-11-09 Roche Diagnostics Corporation Biosensor with code pattern
US6787013B2 (en) 2001-09-10 2004-09-07 Eumed Biotechnology Co., Ltd. Biosensor
JP4264478B2 (en) * 2001-09-28 2009-05-20 アークレイ株式会社 Measuring tool and concentration measuring device
KR100475634B1 (en) 2001-12-24 2005-03-15 주식회사 아이센스 Biosensor equipped with sample introducing part which enables quick introduction of a small amount of sample
US6881578B2 (en) * 2002-04-02 2005-04-19 Lifescan, Inc. Analyte concentration determination meters and methods of using the same
US6743635B2 (en) * 2002-04-25 2004-06-01 Home Diagnostics, Inc. System and methods for blood glucose sensing
US6801041B2 (en) * 2002-05-14 2004-10-05 Abbott Laboratories Sensor having electrode for determining the rate of flow of a fluid
DE20321781U1 (en) * 2002-07-02 2009-12-31 Panasonic Corp., Kadoma Biosensor, biosensor chip and biosensor device
US6939450B2 (en) 2002-10-08 2005-09-06 Abbott Laboratories Device having a flow channel
CA2502272C (en) * 2002-10-16 2011-10-11 Duke University Biosensor
US7501053B2 (en) * 2002-10-23 2009-03-10 Abbott Laboratories Biosensor having improved hematocrit and oxygen biases
US7244264B2 (en) * 2002-12-03 2007-07-17 Roche Diagnostics Operations, Inc. Dual blade lancing test strip
EP1589873B1 (en) * 2003-01-29 2011-12-21 Roche Diagnostics GmbH Integrated lancing test strip
US7452457B2 (en) * 2003-06-20 2008-11-18 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
KR100785670B1 (en) * 2003-06-20 2007-12-14 에프. 호프만-라 로슈 아게 Method and reagent for producing narrow, homogenous reagent strips
US7569126B2 (en) 2004-06-18 2009-08-04 Roche Diagnostics Operations, Inc. System and method for quality assurance of a biosensor test strip
BR112013018941A2 (en) 2011-02-14 2017-03-21 Procter & Gamble film-coated solid dosage forms comprising honey in the coating.

Also Published As

Publication number Publication date
CA2529300A1 (en) 2004-12-29
PL1642124T3 (en) 2018-04-30
EP1642124A1 (en) 2006-04-05
EP3376223A1 (en) 2018-09-19
US20130292266A1 (en) 2013-11-07
CN1839313A (en) 2006-09-27
US7867369B2 (en) 2011-01-11
KR100845163B1 (en) 2008-07-09
ES2657627T3 (en) 2018-03-06
HK1096151A1 (en) 2007-05-25
US8506775B2 (en) 2013-08-13
CN1839313B (en) 2011-12-14
AU2004250223B2 (en) 2007-12-13
JP4489073B2 (en) 2010-06-23
JP2007521484A (en) 2007-08-02
JP4624999B2 (en) 2011-02-02
BRPI0411695A (en) 2006-09-19
WO2005012900A1 (en) 2005-02-10
EP1642125B1 (en) 2017-09-27
CA2529579C (en) 2011-01-25
KR20070100362A (en) 2007-10-10
EP1642125A1 (en) 2006-04-05
CA2529579A1 (en) 2005-02-10
WO2004113910A1 (en) 2004-12-29
US20050023137A1 (en) 2005-02-03
US20050023152A1 (en) 2005-02-03
JP2007524818A (en) 2007-08-30
AU2004250223A1 (en) 2004-12-29
EP1642124B1 (en) 2017-11-29
KR20060022286A (en) 2006-03-09
MXPA05013747A (en) 2006-03-08

Similar Documents

Publication Publication Date Title
CA2529300C (en) Devices and methods relating to electrochemical biosensors
US20200348306A1 (en) Slope-Based Compensation
US8557104B2 (en) In vitro analyte sensor, and methods
US7981363B2 (en) System and method for analyte measurement
US7407811B2 (en) System and method for analyte measurement using AC excitation
US8663442B2 (en) System and method for analyte measurement using dose sufficiency electrodes
US7390667B2 (en) System and method for analyte measurement using AC phase angle measurements
EP2577302B1 (en) Slope-based compensation method including secondary output signals
US20040260511A1 (en) System and method for determining an abused sensor during analyte measurement
JP2003513279A (en) Small volume in vitro analyte sensor and related methods
US20120111739A1 (en) Dual Frequency Impedance Measurement of Hematocrit in Strips

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20180618